Association between obesity and clinical prognosis in patients infected with SARS-CoV-2

被引:36
|
作者
Cai, Shao-Hang [1 ,2 ]
Liao, Wei [3 ,4 ]
Chen, Shu-Wei [4 ,5 ]
Liu, Li-Li [4 ,6 ]
Liu, Si-Yao [7 ]
Zheng, Zhi-Dan [8 ]
机构
[1] Southern Med Univ, Nanfang Hosp, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China
[2] Southern Med Univ, Nanfang Hosp, Hepatol Unit, Guangzhou, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Intens Care Unit, Canc Ctr, Guangzhou, Guangdong, Peoples R China
[4] Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China
[5] Sun Yat Sen Univ, Dept Head & Neck Surg, Canc Ctr, Guangzhou, Guangdong, Peoples R China
[6] Sun Yat Sen Univ, Dept Pathol, Canc Ctr, Guangzhou, Guangdong, Peoples R China
[7] Xiamen Univ, Emergency Dept, Affiliated Hosp 1, Xiamen, Fujian, Peoples R China
[8] Southern Med Univ, Dongguan Peoples Hosp, Dept Infect Dis, Dongguan, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
SARS-CoV-2; Obesity; Body mass index; Prognosis; Pneumonia; Acute respiratory distress syndrome; C-REACTIVE PROTEIN; INFLAMMATION; SENSITIVITY; ADIPONECTIN; CORONAVIRUS; STEATOSIS;
D O I
10.1186/s40249-020-00703-5
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background It is well established that obesity is a disease of sustained low-grade inflammation. However, it is currently unknown if obesity plays a role in the clinical manifestations and prognosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients. In this study, we aimed to investigate whether obesity played a role in clinical manifestations and prognosis in patients infected with SARS-CoV-2. Methods This is a retrospective multicenter clinical study. A total of 96 patients hospitalized with SARS-CoV-2 infection were enrolled from Dongguan People's Hospital, Nanfang hospital and the First Affiliated Hospital of Xiamen University between 23 January and 14 February 2020. Demographic and clinical data were extracted from medical records. Acute respiratory distress syndrome (ARDS) was defined as oxygenation index (PaO2/FiO(2)) <= 300 mmHg. We grouped patients through the body mass index (BMI). Associations were examined using thettest,chi(2)test and multivariate logistic forward regression test. Results Patients with BMI < 24 were significantly younger (P = 0.025) with lower creatine kinase (P = 0.013), lower diastolic pressure blood (P = 0.035), lower serum creatinine (P = 0.012), lower lactate dehydrogenase (P = 0.001) and higher platelet count (P = 0.002). The BMI level was 20.78 +/- 3.15 in patients without pneumonia compared with the patients with pneumonia (23.81 +/- 3.49,P = 0.001). For patients without ARDS, an average BMI level of 22.65 +/- 3.53 was observed, significantly lower than patients with ARDS (24.57 +/- 3.59,P = 0.022). The mean BMI was 22.35 +/- 3.56 in patients experienced with relieving the clinical symptoms or stable condition by radiographic tests, lower than patients with disease exacerbation with 24.89 +/- 3.17 (P = 0.001). In addition, lymphocyte count (r = - 0.23,P = 0.027) and platelet count (r = - 0.44,P < 0.001) were negatively correlated with BMI. While hemoglobin (r = 0.267,P = 0.008), creatine kinase (r = 0.331,P = 0.001), serum creatinine (r = 0.424,P < 0.001) and lactate dehydrogenase (r = 0.343,P = 0.001) were significantly positive correlated with BMI. Multivariate analysis showed that older age (OR = 1.046,P = 0.009) and BMI >= 24 (OR = 1.258,P = 0.005) were independent risk factors associated ICU admission while BMI >= 24 (OR = 4.219,P = 0.007) was independent risk factor associated with radiographic disease exacerbation. Conclusions Our study found BMI was significantly associated with clinical manifestations and prognosis of patients with SARS-CoV-2 infection. For patients with increased risk, clinicians should intervene promptly to avoid disease progression.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Association between obesity and clinical prognosis in patients infected with SARS-CoV-2
    Shao-Hang Cai
    Wei Liao
    Shu-Wei Chen
    Li-Li Liu
    Si-Yao Liu
    Zhi-Dan Zheng
    Infectious Diseases of Poverty, 9
  • [2] Are monoclonal antibodies effective in patients with severe obesity in SARS-CoV-2 infected?
    Ucciferri, Claudio
    Moffa, Livia
    Moffa, Samanta
    Vecchiet, Jacopo
    Falasca, Katia
    IMMUNITY INFLAMMATION AND DISEASE, 2023, 11 (02)
  • [3] Clinical Outcomes of Critically Ill Patients with Obesity Infected With SARS-CoV-2 in New York City
    Takkouche, Sahar
    Hutton, Anneka
    Srivastava, Gitanjali
    OBESITY, 2020, 28 : 67 - 68
  • [4] Clinical Characteristics and Prognosis of COPD Patients Hospitalized with SARS-CoV-2
    Gomez Antunez, Maria
    Muino Miguez, Antonio
    Bendala Estrada, Alejandro David
    Maestro de la Calle, Guillermo
    Monge Monge, Daniel
    Boixeda, Ramon
    Ena, Javier
    Mella Perez, Carmen
    Anton Santos, Juan Miguel
    Lumbreras Bermejo, Carlos
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 3433 - 3445
  • [5] Clinical outcomes and prognosis of patients with HIV and SARS-CoV-2 coinfection
    Patel, Raj H.
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (01) : 105 - 106
  • [6] CLINICAL AND SEROLOGICAL EVOLUTION OF RHEUMATIC PATIENTS INFECTED BY SARS-COV-2
    Navarro, M. De la Rubia
    Cortes, J. Ivorra
    Garcia, E. Grau
    Puig, L. Gonzalez
    Albuixech, R. Negueroles
    Cordellat, I. Martinez
    Ortiz-Sanjuan, F.
    Gil, J. J. Fragio
    Rodriguez, J. E. Oller
    Bernabeu, E. Vicens
    Perales, C. Pavez
    Rodriguez, S. Leal
    Sanchez, L. Mas
    Munoz, P.
    Barcena, C. Riesco
    Quispe, A. V. Huaylla
    Olmos, I. Canovas
    Herranz, C. Najera
    Ivorra, J. A. Roman
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1699 - 1700
  • [7] Clinical characteristics of older and younger patients infected with SARS-CoV-2
    Zhou, Zhiguo
    Zhang, Min
    Wang, Yali
    Zheng, Fang
    Huang, Yaxiong
    Huang, Kang
    Yu, Qizhi
    Cai, Chunlin
    Chen, Dong
    Tian, Yi
    Lei, Jianhua
    Xiao, Xinqiang
    De Clercq, Erik
    Li, Guangdi
    Xie, Yuanlin
    Gong, Guozhong
    AGING-US, 2020, 12 (12): : 11296 - 11305
  • [8] Clinical features of SGTF-infected patients of SARS-CoV-2
    Damayanti, Triya
    Utriyani, Siti Aliyah Said
    Trisnaningrum, Nurindah Saloka
    Kharismarini, Primadea
    Wandawa, Azlina Darsaniya
    Rizki, Mohamad
    Haryanto, Budi
    Maulidina, Aisyah Aminy
    Burhan, Erlina
    RESPIROLOGY, 2023, 28 : 202 - 202
  • [9] Association between vitamin D level and prognostic factors among patients infected with SARS-CoV-2
    Haghighi, Mehrdad
    Ebadi, Seyed Shayan
    Soleimantabar, Hussein
    Shadkam, Atefe
    Ebadi, Seyed Alireza
    Afzali, Hasan
    HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2021, 42 (04) : 345 - 350
  • [10] Association between SARS-CoV-2 viral kinetics and clinical score evolution in hospitalized patients
    Neant, Nadege
    Lingas, Guillaume
    Gaymard, Alexandre
    Belhadi, Drifa
    Hites, Maya
    Staub, Therese
    Greil, Richard
    Paiva, Jose-Artur
    Poissy, Julien
    Peiffer-Smadja, Nathan
    Costagliola, Dominique
    Yazdanpanah, Yazdan
    Bouscambert-Duchamp, Maude
    Gagneux-Brunon, Amandine
    Ader, Florence
    Mentre, France
    Wallet, Florent
    Burdet, Charles
    Guedj, Jeremie
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2023, 12 (12): : 2027 - 2037